Skip to main content

How much does Entyvio cost per month?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on April 21, 2024.

Official answer

by Drugs.com

The cash price for Entyvio is $9,135 for a 300 mg powder for intravenous (IV) injection, using an online coupon, but most people do not pay this amount. After your initial 2 injections in the first month, IV Enytvio is normally given every 8 weeks starting at week 6.

This price does not include costs related to administration of the medicine or any facility fees.

Entyvio also comes as a subcutaneous (under the skin) injection that is given every 2 weeks.

Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Learn more: Entyvio Price Guide: Cost, Coupons and Patient Financial Assistance

Is there a copay coupon for Entyvio?

If you have commercial insurance (for example, through your employer), you may also be eligible for EntyvioConnect, a program from Takeda Pharmaceuticals that can help with out-of-pocket expenses. If you qualify, you may pay as little as $5 per dose every 8 weeks or Takeda can help you find financial assistance.

If you are being treated either by intravenous infusion or subcutaneous injection, you may pay as little as $5 per dose of Entyvio up to a total of $20,000 per year regardless of your insurance coverage. This coverage is valid regardless of your insurance coverage.

Through EntyvioConnect, financial and insurance experts can also help you determine your insurance coverage and if you are eligible for the Entyvio co-pay program to save on out-of-pocket costs.

Patients with private insurance or government sponsored plans will have different costs based on formulary coverage, copay tiers, or any discounts. You may also have costs associated with administration of the IV formulation. Check with your insurance plan for specific costs.

For further assistance, contact Takeda at 1-844-Entyvio (1-844-368-9846). You can also sign up for EntyvioConnect online at entyvio.com/copay-support.

What is Entyvio prescribed for?

Entyvio (vedolizumab) is approved by the FDA to treat adults with moderate to severe ulcerative colitis (UC) or Crohn‘s disease (CD), two inflammatory bowel diseases that affect your gastrointestinal (digestive) tract. It's is classified as an integrin receptor antagonist that works by blocking certain cells to help decrease inflammation in your digestive tract.

Entyvio is given as an intravenous (IV) infusion into a vein in your arm or as a subcutaneous (under the skin) injection from a prefilled pen or syringe. Subcutaneous injections of Entyvio can be self-administered or given by a caregiver at home after training on the injection technique.

After the initial two IV injections (your induction dose), you may received Enytvio every 8 weeks as a 30 minute IV infusion or every 2 weeks as a subcutaneous injection.

Related questions

Does insurance pay for Entyvio?

If you have insurance, your copay for Entyvio will vary based on your formulary coverage or the type of government insurance you have. A formulary is the list of drugs and their copays currently approved by your commercial prescription benefit plan.

If you have commercial insurance, you may be able to get Entyvio for as little as $5 per dose. If you do not have insurance, Takeda may still be able to offer you financial assistance.

Patients who receive governmental-sponsored insurance, such as Medicare, Medicaid, Medicare Part D, Medicare Advantage plans or TriCare are not eligible for the $5 copay program. However, you may still be able to get assistance through an independent copay foundation.

Takeda Pharmaceuticals offers a patient assistance program called EntyvioConnect that offers financial assistance, co-pay support, nurse resources and useful tips to help you manage your condition. You can contact EntyvioConnect at 1-844-ENTYVIO (1-844-368-9846), Monday to Friday, from 8am to 8pm ET (except holidays).

Bottom Line

Entyvio costs $9,135 for for a 300 mg powder for intravenous (IV) injection, using an online coupon. For maintenance treatments, IV formulations are given every 8 weeks and subcutaneous injections are given every 2 weeks.

Intravenous formulations are given at a clinic, in the hospital or doctor's office or even at home, if approved by your doctor and insurance. Subcutaneous (under the skin) injections of Entyvio can be self-administered or given by a caregiver at home after training on the injection technique.

For the IV infusions, there will be added costs due to administration and facility fees.

If you don't have insurance or need other financial assistance, you can speak to a representative at Takeda Pharmaceuticals who can explain your options. Call 1-844-ENTYVIO (1-844-368-9846).

This is not all the information you need to know about Entyvio (vedolizumab) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

Can I take antibiotics while on Entyvio?

The use of Entyvio (generic name: vedolizumab) is not recommended in patients with an active, severe infection until the infection is controlled. Your doctor may consider withholding your Entyvio treatment if you develop a severe infection while on treatment with Entyvio. Your doctor will be able to best decide if you need to take an antibiotic or stop Entyvio treatment. Do not stop taking Entyvio without speaking to your doctor. Continue reading

Entyvio and the COVID vaccine, what should I know?

The Crohn’s & Colitis Foundation recommends that all patients taking Entyvio get vaccinated against COVID-19 with a COVID-19 vaccine, unless advised otherwise by their doctor. Continue reading

Does Entyvio cause weight gain?

Weight gain was not reported as a side effect of Entyvio in clinical trials conducted by the manufacturer. However, when gastrointestinal diseases such as Crohn’s disease or ulcerative colitis improve, patients who have previously lost weight may gain some weight as their illness improves. Continue reading

Related medical questions

Drug information

Related support groups